Context-Aware Optimization of Follow-Up Intervals for Type 2 Diabetes Care Using Markov Decision Processes
arXiv:2606.19092v1 Announce Type: cross Abstract: Chronic disease management relies on regular patient-provider interactions to follow-up on disease progression and control. For Type 2 Diabetes (T2D), current guidelines prescribe fixed time intervals between subsequent primary care visits for all patients, overlooking heterogeneity in clinical trajectories and patient characteristics. This study introduces a Contextual Markov Decision Process (CMDP) model to optimize subpopulation-specific follow-up interval decisions using Electronic Health Record (EHR) data from 22,154 T2D patients across 10
The proliferation of Electronic Health Records (EHR) and advancements in AI/ML, specifically Markov Decision Processes, are enabling more sophisticated, data-driven approaches to chronic disease management.
This development highlights how AI is moving beyond general intelligence to highly specific, impactful applications within healthcare, potentially optimizing patient outcomes and healthcare resource allocation.
Healthcare guidelines for chronic diseases, currently based on fixed intervals, may evolve to dynamic, personalized schedules, improving care efficiency and effectiveness for specific patient subpopulations.
- · Healthcare AI companies
- · Patients with chronic diseases
- · Healthcare systems
- · EHR providers
- · Traditional medical guideline bodies slow to adapt
- · Healthcare providers resistant to AI integration
Individualized patient care plans based on predictive analytics will become more common for chronic disease management.
This model could be extended to other chronic conditions, leading to widespread recalibration of follow-up protocols across healthcare.
The success of such AI-driven interventions could accelerate demand for more standardized and extensive healthcare data collection and interoperability.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG